Overview

Description

  • NatureSynthetic

Associated products

Specifications

Our Abpromise guarantee covers the use of ab74827 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Purity70 - 90% by HPLC.

  • FormLiquid
  • Additional notes

    - First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.
    - If the peptide doesn’t dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
    - Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
    - Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
    - Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

    Information available upon request.

General Info

  • Alternative names
    • Charcot Marie Tooth neuropathy 2A
    • CMT 2
    • CMT 2A
    • CMT 2A1
    • CMT2
    • CMT2 A
    • CMT2 A1
    • CMT2A
    • CMT2A 1
    • CMT2A1
    • D4Mil1e
    • HMSN II
    • HMSNII
    • HMSNII, hereditary motor sensory neuropathy II
    • KIF 1B
    • KIF1 B
    • KIF1B p130
    • KIF1B p204
    • KIF1Bp130
    • KIF1Bp204
    • kinesin family member 1B
    • Kinesin like protein KIF1B
    • Klp
    see all
  • RelevanceKIF1B, or kinesin-like protein (Klp) functions as a motor for mitochondrial transport, and has a microtubule plus end-directed motility. The KIF1B beta isoform is abundant in brain, while the alpha isoform is abundant in skeletal muscle. Mutations in the KIF1B gene are the cause of Charcot-Marie-Tooth disease type 2A1, which is a primary peripheral axon neuropathy. The KIF1B beta isoform is down-regulated in sporadic amyotrophic lateral sclerosis (ALS).
  • Cellular localizationCytoplasmic and Mitochondrial

References for Human KIF1B peptide (ab74827)

ab74827 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab74827.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"